Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons
Hiroshi Yamamoto, … , Daniel J. Drucker, Joel K. Elmquist
Hiroshi Yamamoto, … , Daniel J. Drucker, Joel K. Elmquist
Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):43-52. https://doi.org/10.1172/JCI15595.
View: Text | PDF
Article Aging

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

  • Text
  • PDF
Abstract

Research Article

Authors

Hiroshi Yamamoto, Charlotte E. Lee, Jacob N. Marcus, Todd D. Williams, J. Michael Overton, Marisol E. Lopez, Anthony N. Hollenberg, Laurie Baggio, Clifford B. Saper, Daniel J. Drucker, Joel K. Elmquist

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Distribution of i.v. EXN-4–induced Fos-IR in the brain. A series of phot...
Distribution of i.v. EXN-4–induced Fos-IR in the brain. A series of photomicrographs demonstrates Fos-IR in neurons 2 hours after i.v. administration of EXN-4 (first and third columns) or PFS (second and fourth columns) in several brain regions. These regions include (a and b) the paraventricular nucleus of the hypothalamus (PVH); (c and d) the lateral hypothalamic area (LHA); (e and f) the arcuate nucleus (Arc) and the retrochiasmatic area (RCA); (g and h) the external lateral subdivision of the parabrachial nucleus (PBel); (i and j) the locus coeruleus (LC); (k and l) the A5 cell group (A5); (m and n) the area postrema (AP) and the NTS; (o and p) the rostral ventrolateral medulla (RVML); (q and r) the caudal ventrolateral medulla (CVLM); and (s and t) the IML in the spinal cord. 3v, third ventricle; f, fornix; 4v, fourth ventricle; VII, facial nerve. Scale bar = 250 μm in a–d, g, and h, and 100 μm in e, f, and i–t.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts